Objective: To evaluate the impact of the pharmaceutical intervention in the improvement of the medication adherence of the patients
with HIV and AIDS, and to identify the factors that infl uence on medication adherence and which one could be modifi ed by the pharmaceutical
intervention during pharmaceutical care.
Methods: Pharmacotherapeutic follow-up was realized for 23 months to 52 patients, older than 18 years, with antiretroviral treatment
for up to three months, consent informed was obtained from patients. Medication adherence was evaluated with CEAT-HIV (questionnaire
to evaluate the adhesion to the antiretroviral treatment) at the beginning and at the end of the study (6 months).
Results: The fi nal score from CEAT-HIV (p <0.05; 95% IC), treatment compliance (p <0.001) and patient’s beliefs to the disease and
antiretroviral treatment (p <0.001) improved signifi cantly with the pharmaceutical intervention. The more frequent pharmaceutical intervention
was education to the patient to increment the adherence to the treatment (46%).
Conclusion: These results demonstrate that the pharmacists’ intervention through pharmacotherapeutic follow-up improves the adherence
to the antiretroviral treatment. The pharmacist was able to improve aspects of compliance and patient’s beliefs about the
treatment and disease. The pharmacist could utilize CEAT-VIH as an instrument to evaluate the adherence in HIV/AIDS patients.
Authors: Tafur Valderrama, E.J.; Ortiz Alfaro, C.; García-Jiménez, E.; Faus Dader, M.J.; Martínez Martínez, F.
Source: Pharm Care Esp
URL: http://hdl.handle.net/10757/314353
No hay comentarios:
Publicar un comentario